clemastine has been researched along with Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boere, IA; Bosch, TM; Cox, JM; Jager, A; Malmberg, R; Mathijssen, RHJ; Oomen-de Hoop, E; van den Bemt, PMLA; van Doorn, L; van Leeuwen, RWF | 1 |
| Ekins, S; Puhl, AC; Urbina, F | 1 |
| Freund, W; Hausamen, TU; Lipke, J; Löffler, TM | 1 |
| Heymanns, J; Köppler, H; Weide, R | 1 |
1 review(s) available for clemastine and Neoplasms
| Article | Year |
|---|---|
Recent advances in drug repurposing using machine learning.
Topics: Alzheimer Disease; Antineoplastic Agents; Antiviral Agents; Clemastine; Computational Biology; COVID-19 Drug Treatment; Dipyridamole; Drug Repositioning; Humans; Hydroxychloroquine; Lenalidomide; Machine Learning; Neoplasms; Neuroprotective Agents; Piperazines; Piperidines; Protein Kinase Inhibitors | 2021 |
3 trial(s) available for clemastine and Neoplasms
| Article | Year |
|---|---|
The added value of H
Topics: Adult; Aged; Aged, 80 and over; Chemoprevention; Clemastine; Dexamethasone; Drug Hypersensitivity; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Male; Medical Futility; Middle Aged; Neoplasms; Netherlands; Paclitaxel; Premedication; Ranitidine; Severity of Illness Index; Treatment Outcome | 2021 |
Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial.
Topics: Adult; Aged; Anti-Allergic Agents; Antiemetics; Antineoplastic Agents, Phytogenic; Cimetidine; Clemastine; Dexamethasone; Drug Administration Schedule; Female; Histamine H2 Antagonists; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Ondansetron; Paclitaxel | 1996 |
Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions.
Topics: Adult; Aged; Aged, 80 and over; Anaphylaxis; Clemastine; Dexamethasone; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Paclitaxel; Premedication; Ranitidine; Treatment Outcome | 2001 |